全文获取类型
收费全文 | 839篇 |
免费 | 69篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 7篇 |
妇产科学 | 14篇 |
基础医学 | 30篇 |
口腔科学 | 136篇 |
临床医学 | 58篇 |
内科学 | 103篇 |
皮肤病学 | 27篇 |
神经病学 | 3篇 |
特种医学 | 21篇 |
外科学 | 12篇 |
综合类 | 125篇 |
预防医学 | 10篇 |
眼科学 | 3篇 |
药学 | 336篇 |
中国医学 | 45篇 |
肿瘤学 | 13篇 |
出版年
2024年 | 1篇 |
2023年 | 7篇 |
2022年 | 6篇 |
2021年 | 10篇 |
2020年 | 15篇 |
2019年 | 18篇 |
2018年 | 14篇 |
2017年 | 18篇 |
2016年 | 23篇 |
2015年 | 21篇 |
2014年 | 35篇 |
2013年 | 66篇 |
2012年 | 33篇 |
2011年 | 38篇 |
2010年 | 30篇 |
2009年 | 30篇 |
2008年 | 25篇 |
2007年 | 44篇 |
2006年 | 44篇 |
2005年 | 42篇 |
2004年 | 28篇 |
2003年 | 33篇 |
2002年 | 52篇 |
2001年 | 32篇 |
2000年 | 36篇 |
1999年 | 28篇 |
1998年 | 29篇 |
1997年 | 29篇 |
1996年 | 23篇 |
1995年 | 17篇 |
1994年 | 17篇 |
1993年 | 10篇 |
1992年 | 14篇 |
1991年 | 10篇 |
1990年 | 8篇 |
1989年 | 8篇 |
1988年 | 11篇 |
1987年 | 7篇 |
1986年 | 11篇 |
1985年 | 8篇 |
1984年 | 7篇 |
1983年 | 1篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1974年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有945条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
目的观察中药妇炎舒胶囊联合盐酸左氧氟沙星片和甲硝唑片治疗慢性盆腔炎患者的疗效和相关炎性因子的影响。方法收取118例湿热瘀结型慢性盆腔炎的患者,随机分为实验组(A组)和对照组(B组)各59例。A组给予妇炎舒胶囊56 d,B组妇炎舒胶囊模拟剂56 d,两组均服用盐酸左氧氟沙星片+甲硝唑片用药14 d。患者服药56 d后观察临床有效率及治疗前后血清中肿瘤坏死因子-α(Tumor necrosis factor,TNF-α),干扰素-γ(Interferon,IFN-γ)因子含量的变化;随访1个月经周期后观察者复发率及慢性盆腔痛情况。结果(1)A组中医证候积分有效率明显高于B组,且差异有统计学意义(P<0.01)。(2)治疗后A组患者外周血中TNF-α和IFN-γ的含量明显低于B组,具有显著统计学差异(P<0.01)。(3)A组随访复发率(10.17%vs 96.61%)和后遗盆腔痛(18.64%vs 86.44%)均显著低于B组(P<0.01)。结论中药妇炎舒胶囊联合抗生素治疗湿热瘀结型慢性盆腔炎疗效显著,并能够降低慢性盆腔炎的复发率和慢性盆腔痛,并能通过适当降低外周血中TNF-α、IFN-γ等炎性因子的形成,起到治疗作用。 相似文献
5.
6.
大鼠下颌骨来源的成骨细胞对甲硝唑和替硝唑的转运 总被引:14,自引:3,他引:14
目的:应用SD大鼠下颔骨来源的原代成骨细胞,观察成骨细胞对甲硝唑和替硝唑的转运,探讨人工种植牙给药的影响及可行性。方法:将原代培养的新生鼠成骨细胞(newborn rat’s osteoblast,N)和成年鼠成骨细胞(adult rat’s osteoblast,A)与溶于PBS的药物共同孵育,分别于1,3,5,10min后,弃去细胞外液,收集各时间点细胞悬液,用高效液相色谱法测定细胞内药物量,用考马斯亮蓝法测定细胞蛋白总量。结果:(1)高效液相色谱法可以准确测定2种药物的量。(2)2种成骨细胞均可将甲硝唑和替硝唑转运至细胞内。结论:成骨细胞具有转运硝基眯唑类药物的能力,证实了人工种植牙给药的可行性。 相似文献
7.
Feres M Haffajee AD Allard K Som S Goodson JM Socransky SS 《Journal of clinical periodontology》2002,29(8):724-735
AIM: The purpose of the present investigation was to determine the percentage and identity of antibiotic-resistant species in subgingival plaque and saliva samples from chronic periodontitis patients treated by scaling and root planing followed by orally administered amoxicillin or metronidazole. METHOD: In all, 20 chronic periodontitis patients were selected for study. After clinical and microbiological monitoring, subjects were randomly assigned to receive either orally administered amoxicillin at the dosage of 500 mg, 3 times daily for 14 days or orally administered metronidazole at the dosage of 250 mg, 3 times daily for 14 days. For the antibiotic resistance determinations, subgingival plaque samples were taken from six posterior teeth at baseline, and 90 days; and from two randomly selected teeth at 3, 7 and 14 days during and after antibiotic administration. Samples were plated on enriched blood agar plates with or without either 2 micro g/mL metronidazole or 2 micro g/mL amoxicillin. Colonies were counted at 7 days. Significant differences in percentage of resistant organisms over time were determined by the Quade test. Microbial growth was washed from antibiotic-containing media and the identity of species determined using checkerboard DNA-DNA hybridization. Data were compared with those obtained in a previous study from subjects receiving SRP only or SRP followed by 14 days of orally administered doxycycline. The level of doxycycline used to determine antibiotic resistance in that study was 4 micro g/mL. RESULTS: The mean percentage of resistant isolates increased during antibiotic administration and returned to baseline levels by 90 days post therapy. The mean percentages (+/- SEM) of isolates resistant to 2 micro g/mL metronidazole were 53 +/- 9, 65 +/- 9, 79 +/- 4 and 69 +/- 7 at baseline, 3, 7 and 14 days during antibiotic administration, and 57 +/- 4, 64 +/- 5, 62 +/- 7 and 47 +/- 6 at 3, 7, 14 and 90 days after antibiotic administration. At the same time points, the percentage of resistant isolates to amoxicillin was 0.5 +/- 0.2, 22 +/- 12, 14 +/- 5 and 37 +/- 11 during, and 31 +/- 11, 8 +/- 3, 3 +/- 2 and 3 +/- 0.6 after, administration. Antibiotic-resistant isolates of resistant species detected during or after therapy were also detected prior to therapy. The most prevalent resistant species in the metronidazole-treated group were: A. naeslundii 1, S. constellatus, A. naeslundii 2, S. mitis, S. oralis, A. odontolyticus, S. sanguis, and in the amoxicillin-treated group: S. constellatus, P. nigrescens, E. saburreum, A. naeslundii 1, S. oralis, P. melaninogenica and P. intermedia. CONCLUSIONS: Systemic antibiotic administration transiently increased the percentage of resistant subgingival species, but a major component of subgingival plaque remained sensitive to the agents during their administration. Antibiotic-resistant isolates of resistant species could be detected in samples both prior to and after therapy. However, % antibiotic-resistant isolates returned to baseline levels 90 days after antibiotic administration. 相似文献
8.
Treatment of periodontal infections due to anaerobic bacteria with short-term treatment with metronidazole 总被引:6,自引:0,他引:6
W. J. Loesche S. A. Syed E. C. Morrison B. Laughon N. S. Grossman 《Journal of clinical periodontology》1981,8(1):29-44
Abstract In the present report, five selected periodontal patients were treated for 1 week with metronidazole. Two of the patients had their teeth scaled and root-planed the week they received metronidazole. Prior to treatment, B. asaccharolyticus accounted for 41 % of the cultivable isolates and the spirochetes averaged 29 % of the microscopic count in plaque removed from each of four pockets per patient. The presence of these elevated proportions of periodontopathic bacteria combined with the presence of periodontal pockets and attachment loss suggested that the patients were in a state of an active infectious process involving primarily anaerobic bacteria. If this be the case, then antimicrobial therapy directed against these anaerobes with metronidazole was indicated. The 1-week treatment with metronidazole significantly reduced the proportions of these organisms for up to 6 months after treatment. Coincident with these findings was an improvement in the clinical parameters, especially in those sites that initially had greater than 5 mm pocket or attachment loss. These sites showed a 2 mm or more reduction in pocket depth and an almost 2 mm gain in apparent attachment that was evident 6 months after treatment. The results obtained were in only five patients. However, the magnitude of improvement suggests that antimicrobial therapy directed against anaerobic organisms may be a valuable adjunct to periodontal therapy. 相似文献
9.
Winkel EG Van Winkelhoff AJ Timmerman MF Van der Velden U Van der Weijden GA 《Journal of clinical periodontology》2001,28(4):296-305
BACKGROUND, AIMS: The aim of this double-blind, parallel study was to evaluate the adjunctive effects of systemically administered amoxicillin and metronidazole in a group of adult periodontitis patients who also received supra- and subgingival debridement. METHODS: 49 patients with a diagnosis of generalised severe periodontitis participated in the study. Random assignment resulted in 26 patients in the placebo (P) group with a mean age of 40 years and 23 patients in the test (T) group which had a mean age of 45 years. Clinical measurements and microbiological assessments were taken at baseline and 3 months after completion of initial periodontal therapy with additional placebo or antibiotic treatment. Patients received coded study medication of either 375 mg amoxicillin in combination with 250 mg metronidazole or identical placebo tablets, every 8 hours for the following 7 days. RESULTS: At baseline, no statistically significant differences between groups were found for any of the clinical parameters. Except for the plaque, there was a significantly larger change in the bleeding, probing pocket depth (PPD) and clinical attachment level (CAL) in the T-group as compared to the P-group after therapy. The greatest reduction in PPD was found at sites with initial PPD of > or = 7 mm, 2.5 mm in the P-group and 3.2 mm in the T-group. The improvement in CAL was most pronounced in the PPD category > or = 7 mm and amounted to 1.5 mm and 2.0 mm in the P- and T-groups, respectively. No significant decrease was found in the number of patients positive for any of the test species in the P-group. The number of patients positive for Porphyromonas gingivalis, Bacteroides forsythus and Prevotella intermedia in the T-group showed a significant decrease. After therapy there was a significant difference between the P- and the T- group in the remaining number of patients positive for P. gingivalis, B. forsythus and Peptostreptococcus micros. 4 subgroups were created on the basis of the initial microbiological status for P. gingivalis positive (Pg-pos) and negative patients (Pg-neg) in the P- and the T-groups. The difference in reduction of PPD between Pg-pos and Pg-neg patients was particularly evident with respect to the changes in % of sites with a probing pocket depth > or = 5 mm. This % decreased from 45% at baseline to 23% after treatment in the Pg-pos placebo subgroup and decreased from 46% to 11% in the Pg-pos test subgroup (p < or = 0.005). In contrast, the changes in the proportions of sites with a probing pocket depth > or = 5 mm in the Pg-neg placebo and Pg-neg test subgroup were similar, from 43% at baseline to 18% after treatment versus 40% to 12% respectively. CONCLUSIONS: This study has shown that systemic usage of metronidazole and amoxicillin, when used in conjunction with initial periodontal treatment in adult periodontitis patients, achieves significantly better clinical and microbiological results than initial periodontal treatment alone. Moreover, this research suggests that especially patients diagnosed with P. gingivalis benefit from antibiotic treatment. 相似文献
10.
本文研制了治疗牙周炎的复方甲硝唑缓释膜剂.为证实其对牙周病的治疗作用,进行了体外抑菌试验和临床应用.结果表明,该缓释膜剂对牙周病优势菌有明显抑制效果;经临床观察使用该药膜一周后,菌斑指数(PLI)、牙龈指数(GI)、龈沟出血指数(SBI)及牙周袋深度(PD)均显著降低,证明复方甲硝唑缓释膜剂治疗牙周病有广阔前景. 相似文献